Liquid formulation of long-acting human growth hormone conjugate
    3.
    发明授权
    Liquid formulation of long-acting human growth hormone conjugate 有权
    长效人生长激素结合物的液体制剂

    公开(公告)号:US09061072B2

    公开(公告)日:2015-06-23

    申请号:US13809783

    申请日:2011-07-14

    摘要: Disclosed is a liquid formulation of long-acting human growth hormone (hGH) conjugate, free of albumin, which can guarantee the stability of the long-acting hGH conjugate when stored over a long period of time, wherein the long-acting human growth hormone conjugate includes a human growth hormone linked to an immunoglobulin Fc region, and has a prolonged in vivo stability compared to the native form. The liquid formulation of hGH conjugate including a pH 5.0˜6.0 buffer, a sugar alcohol, a salt and a non-ionic surfactant is free of human serum albumin and other hazardous factors which are potentially contaminated with viruses, and can provide excellent storage stability customized for a long-acting hGH conjugate composed of an hGH polypeptide and an immunoglobulin Fc region which has higher molecular weight and in vivo durability, compared to the native.

    摘要翻译: 公开了长效人生长激素(hGH)缀合物的液体制剂,其不含白蛋白,其可以长期保存长效hGH缀合物的稳定性,其中长效人生长激素 缀合物包括与免疫球蛋白Fc区连接的人生长激素,并且与天然形式相比具有延长的体内稳定性。 包含pH 5.0〜6.0缓冲液,糖醇,盐和非离子表面活性剂的hGH缀合物的液体制剂不含人血清白蛋白和潜在的病毒污染的其他有害因素,可提供优良的储存稳定性 对于由hGH多肽和具有较高分子量和体内耐久性的免疫球蛋白Fc区组成的长效hGH缀合物,与天然产物相比。

    LIQUID FORMULATION OF LONG-ACTING HUMAN GROWTH HORMONE CONJUGATE
    4.
    发明申请
    LIQUID FORMULATION OF LONG-ACTING HUMAN GROWTH HORMONE CONJUGATE 有权
    长寿命人体生长激素联合液的液体配方

    公开(公告)号:US20130115231A1

    公开(公告)日:2013-05-09

    申请号:US13809783

    申请日:2011-07-14

    IPC分类号: A61K47/48

    摘要: Disclosed is a liquid formulation of long-acting human growth hormone (hGH) conjugate, free of albumin, which can guarantee the stability of the long-acting hGH conjugate when stored over a long period of time, wherein the long-acting human growth hormone conjugate includes a human growth hormone linked to an immunoglobulin Fc region, and has a prolonged in vivo stability compared to the native form. The liquid formulation of hGH conjugate including a pH 5.0˜6.0 buffer, a sugar alcohol, a salt and a non-ionic surfactant is free of human serum albumin and other hazardous factors which are potentially contaminated with viruses, and can provide excellent storage stability customized for a long-acting hGH conjugate composed of an hGH polypeptide and an immunoglobulin Fc region which has higher molecular weight and in vivo durability, compared to the native.

    摘要翻译: 公开了长效人生长激素(hGH)缀合物的液体制剂,其不含白蛋白,其可以长期保存长效hGH缀合物的稳定性,其中长效人生长激素 缀合物包括与免疫球蛋白Fc区连接的人生长激素,并且与天然形式相比具有延长的体内稳定性。 包含pH 5.0〜6.0缓冲液,糖醇,盐和非离子表面活性剂的hGH缀合物的液体制剂不含人血清白蛋白和其他可能被病毒污染的危险因素,可以提供优良的储存稳定性 对于由hGH多肽和具有较高分子量和体内耐久性的免疫球蛋白Fc区组成的长效hGH缀合物,与天然产物相比。

    LIQUID FORMULATIONS FOR LONG-ACTING G-CSF CONJUGATE
    9.
    发明申请
    LIQUID FORMULATIONS FOR LONG-ACTING G-CSF CONJUGATE 有权
    用于长时间运动G-CSF凝血液的液体制剂

    公开(公告)号:US20120294829A1

    公开(公告)日:2012-11-22

    申请号:US13574039

    申请日:2011-01-18

    IPC分类号: A61K38/19

    摘要: Disclosed is a liquid formulation which allows long-acting G-CSF conjugates, that have improved in vivo duration and stability, to be stable when stored for a long period of time. It comprises a stabilizer composition characterized by buffer and mannitol. Being free of human serum albumin and other potential factors harmful to the body, the liquid formulation is free of concerns about viral infections and guarantees excellent storage stability to long-acting G-CSF conjugates.

    摘要翻译: 本发明公开了一种允许长效G-CSF缀合物的液体制剂,其具有改善的体内持续时间和稳定性,在长时间储存​​时是稳定的。 它包括以缓冲液和甘露醇为特征的稳定剂组合物。 没有人体血清白蛋白和其他对身体有害的潜在因素,液体制剂没有对病毒感染的担忧,并保证了对长效G-CSF缀合物的极好的储存稳定性。